DURHAM, N.C., September 12, 2017 — Osteoarthritis is the leading cause of disability due to pain and the most common form of arthritis, afflicting an estimated 237 million people worldwide. At a live webinar on Tuesday, September 19 (11am EDT / 4pm BST / 5pm CEST), Premier Research will examine new approaches to one of the most enduring challenges in analgesic drug development.
Chronic Pain: Conducting Clinical Trials in Osteoarthritis will examine:
- Osteoarthritis as a flexible model for development of new therapies.
- Design of clinical trial protocols to address the special needs of the drugs under study.
- Differences among common data analysis methods.
- Study design features that reduce placebo effects.
Register now for an informative look at how medical science is giving new hope to the millions who suffer from this widely debilitating condition.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,100 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.